Cargando…
Sequence-to-expression approach to identify etiological non-coding DNA variations in P53 and cMYC-driven diseases
BACKGROUND AND METHODS: Disease risk prediction based on DNA sequence and transcriptional profile can improve disease screening, prevention, and potential therapeutic approaches by revealing contributing genetic factors and altered regulatory networks. Despite identifying many disease-associated DNA...
Autores principales: | Kin, Katherine, Bhogale, Shounak, Zhu, Lisha, Thomas, Derrick, Bertol, Jessica, Zheng, W. Jim, Sinha, Saurabh, Fakhouri, Walid D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371153/ https://www.ncbi.nlm.nih.gov/pubmed/37503250 http://dx.doi.org/10.21203/rs.3.rs-3037310/v1 |
Ejemplares similares
-
Thermodynamics-based modeling reveals regulatory effects of indirect transcription factor-DNA binding
por: Bhogale, Shounak, et al.
Publicado: (2022) -
A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010) -
Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012) -
The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc()()
por: Prensner, John R., et al.
Publicado: (2014) -
Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)